Gene · 6281
Papers4,430
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 4,430
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| AuNPs/CNC Nanocomposite with A "Dual Dispersion" Effect for LDI-TOF MS Analysis of Intact Proteins in NSCLC Serum Exosomes. | Adv Sci (Weinh) | 2024 | 38224220 | PubTator, text mining | PubMed |
| Cryo-EM structure and functional landscape of an RNA polymerase ribozyme. | Proc Natl Acad Sci U S A | 2024 | 38207080 | PubTator, text mining | PubMed |
| Disruption of lysosomal proteolysis in astrocytes facilitates midbrain organoid proteostasis failure in an early-onset Parkinson's disease model. | Nat Commun | 2024 | 38200091 | PubTator, text mining | PubMed |
| Characterizing immune variation and diagnostic indicators of preeclampsia by single-cell RNA sequencing and machine learning. | Commun Biol | 2024 | 38182876 | PubTator, text mining | PubMed |
| Pathological phenotypes of astrocytes in Alzheimer's disease. | Exp Mol Med | 2024 | 38172603 | PubTator, text mining | PubMed |
| Identification and characterization of calreticulin as a novel plasminogen receptor. | J Biol Chem | 2024 | 37979915 | PubTator, text mining | PubMed |
| Plasminogen deficiency suppresses pancreatic ductal adenocarcinoma disease progression. | Mol Oncol | 2024 | 37971174 | PubTator, text mining | PubMed |
| Single-cell analysis of immune recognition in chronic myeloid leukemia patients following tyrosine kinase inhibitor discontinuation. | Leukemia | 2024 | 37919606 | PubTator, text mining | PubMed |
| Perspective from single-cell sequencing: Is inflammation in acute ischemic stroke beneficial or detrimental? | CNS Neurosci Ther | 2024 | 37905592 | PubTator, text mining | PubMed |
| Hidden evolutionary constraints dictate the retention of coronavirus accessory genes. | bioRxiv | 2024 | 37873270 | PubTator, text mining | PubMed |
| Succinylation modification: a potential therapeutic target in stroke. | Neural Regen Res | 2024 | 37843212 | PubTator, text mining | PubMed |
| Star power: harnessing the reactive astrocyte response to promote remyelination in multiple sclerosis. | Neural Regen Res | 2024 | 37721287 | PubTator, text mining | PubMed |
| Molecular Activation of NLRP3 Inflammasome by Particles and Crystals: A Continuing Challenge of Immunology and Toxicology. | Annu Rev Pharmacol Toxicol | 2024 | 37708431 | PubTator, text mining | PubMed |
| Interactions and conformational changes of annexin A2/p11 heterotetramer models on a membrane: a molecular dynamics study. | J Biomol Struct Dyn | 2024 | 37705315 | PubTator, text mining | PubMed |
| Irish general practitioner (GP) perspectives on impact of direct access radiology on patient care in the community: results from a mixed-methods study. | Ir J Med Sci | 2024 | 37354242 | PubTator, text mining | PubMed |
| The Role of Microglia in Brain Metastases: Mechanisms and Strategies. | Aging Dis | 2024 | 37307835 | PubTator, text mining | PubMed |
| Modeling the Annexin A1-S100A11 heterotetramer: a molecular dynamics investigation of structure and correlated motion. | J Biomol Struct Dyn | 2024 | 37194290 | PubTator, text mining | PubMed |
| Discovery of potential quality markers of Fritillariae thunbergii bulbus in pneumonia by combining UPLC-QTOF-MS, network pharmacology, and molecular docking. | Mol Divers | 2024 | 36843054 | PubTator, text mining | PubMed |
| Analyses of the autism-associated neuroligin-3 R451C mutation in human neurons reveal a gain-of-function synaptic mechanism. | Mol Psychiatry | 2024 | 36280753 | PubTator, text mining | PubMed |
| Translational implications of targeting annexin A2: From membrane repair to muscular dystrophy, cardiovascular disease and cancer. | Clin Transl Discov | 2023 | 38465198 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6281/papers?page=11